Temperament, character, and personality disorders in chronic pain topical collection on psychiatric management of pain

Current Pain and Headache Reports

Volumn 17, Issue 3, 2013, Pages

  Conrad, Rupert ^a   Wegener, Ingo ^a   Geiser, Franziska ^a   Kleiman, Alexandra ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Amygdala; Character; Chronic Pain; Cooperativeness; Fibromyalgia; Harm Avoidance; MMPI; NEO PI; Novelty Seeking; Persistence; Personality Disorders; Reward Dependence; Robert Cloninger; Self Directedness; Self Transcendence; Serotonin; TCI; Temperament

Indexed keywords

CHRONIC PAIN; HUMAN; REVIEW; TEMPERAMENT; CHARACTER; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMPIRICAL RESEARCH; FEMALE; MALE; METHODOLOGY; PERSONALITY DISORDER; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; QUESTIONNAIRE; UNITED STATES;

CHARACTER; CHRONIC PAIN; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMPIRICAL RESEARCH; FEMALE; HUMANS; MALE; MODELS, PSYCHOLOGICAL; PERSONALITY DISORDERS; PERSONALITY INVENTORY; QUESTIONNAIRES; TEMPERAMENT; UNITED STATES;

MLCS; MLOWN;

EID: 84874647102     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-012-0318-3     Document Type: Review

References (75)

1. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50(12):975-90. (Pubitemid 23361478)
2. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987;44(6):573-88. (Pubitemid 17082099)
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, D.C.; 2000.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-V). Washington, D.C.; 2010.
5. Emil K. Lectures on clinical psychiatry. New York: William Wood & Co; 1904.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). 4th text revised ed. Washington, D.C.; 2000.
7. Cloninger CR, Svrakic D. Personality disorders. In: Fatemi SH, Clayton P, editors. The medical basis of psychiatry. Humana Press; 2008: p. 471-83.
8. Svrakic DM, Whitehead C, Przybeck TR, Cloninger CR. Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Arch Gen Psychiatry. 1993;50(12):991-9. (Pubitemid 23361479)
9. Svrakic DM, Draganic S, Hill K, et al. Temperament, character, and personality disorders: etiologic, diagnostic, treatment issues. Acta Psychiatr Scand. 2002;106(3):189-95.
10. Weisberg JN, Keefe FJ. Personality, individual differences and psychopathology in chronic pain. In: Gatchel RJ, Turk DC, editors. Psychosocial factors in pain: critical perspectives. New York: Guilford Press; 1999. p. 56-73.
11. Engel GL. Psychogenic pain and pain-prone patient. Am J Med. 1959;26(6):899-918.
12. McKinley JHS. The identification and measurement of the psychoneuroses in medical practice: the minnesota multiphasic personality inventory. JAMA. 1943;122(3):161-7.
13. Butcher JN. Minnesota Multiphasic Personality Inventory. The Corsini Encyclopedia of Psychology. John Wiley & Sons, Inc.; 2010.
14. Costa P, McCrae R. Normal personality assessment in clinical practice: the NEO Personality Inventory. Psychol Assess. 1992;4(1):5-13.
15. Sternbach RA. Pain patients: traits and treatment. New York: Academic Press; 1974.
16. Bradley LA, Prokop CK, Margolis R, Gentry WD. Multivariate analyses of the MMPI profiles of low back pain patients. J Behav Med. 1978;1(3):253-72. (Pubitemid 10247038)
17. Armentrout DP, Moore JE, Parker JC, et al. Pain-patient MMPI subgroups: the psychological dimensions of pain. J Behav Med. 1982;5(2):201-11. (Pubitemid 12026562)
18. Wade JB, Dougherty LM, Hart RP, Cook DB. Patterns of normal personality structure among chronic pain patients. Pain. 1992;48(1):37-43.
19. Banks SM, Kerns RD. Explaining high rates of depression in chronic pain: a diathesis-stress framework. Psychol Bull. 1996;119:95-110. (Pubitemid 126021387)
20. Weisberg JN, Keefe FJ. Personality disorders in the chronic pain population: basic concepts, empirical findings, and clinical implications. Pain Forum. 1997;6(1):1-9.
21. Gatchel RJ, Peng YB, Peters ML, et al. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. 2007;133(4):581-624.
22. • Gencay-Can A, Can SS. Temperament and character profile of patients with fibromyalgia. Rheumatol Int. 2011. The most recent study on temperament and character in fibromyalgia.
23. •• Mazza M, Mazza O, Pomponi M, et al. What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia? Comprehensive psychiatry. 2009;50:240-4. This study demonstrates significant positive effects of SSRI treatment on harm avoidance and self-directedness scores in patients with fibromyalgia.
24. • Glazer Y, Buskila D, Cohen H, et al. Differences in the personality profile of fibromyalgia patients and their relatives with and without fibromyalgia. Clin Exp Rheumatol. 2010;28(6 Suppl 63):S27-32. This study investigates temperament and character profile in fibromyalgia patients and their relatives.
25. Lundberg G, Anderberg UM, Gerdle B. Personality features in female fibromyalgia syndrome. J Musculoskel Pain. 2009;17:117-30.
26. Di Piero V, Bruti G, Venturi P, et al. Aminergic tone correlates of migraine and tension-type headache: a study using the tridimensional personality questionnaire. Headache. 2001;41(1):63-71. (Pubitemid 32147869)
27. Mongini F, Fassino S, Rota E, et al. The temperament and character inventory in women with migraine. J Headache Pain. 2005;6(4):247-9. (Pubitemid 41349316)
28. Sánchez-Román S, Téllez-Zenteno JF, Zermeño-Phols F, et al. Personality in patients with migraine evaluated with the "Temperament and Character Inventory". J Headache Pain. 2007;8:94-104. (Pubitemid 46796393)
29. Boz C, Gazioglu S, Altunayoglu V, Hocaoglu C. Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache. Psychiatry Clin Neurosci. 2007;61:534-42. (Pubitemid 47414856)
30. Boz C, Velioglu S, Ozmenoglu M, et al. Temperament and character profiles of patients with tension-type headache and migraine. Psychiatry Clin Neurosci. 2004;58(5):536-43. (Pubitemid 39468798)
31. Abbate-Daga G, Fassino S, Lo GR, et al. Anger, depression and personality dimensions in patients with migraine without aura. Psychother Psychosom. 2007;76:122-8. (Pubitemid 46145641)
32. Conrad R, Schilling G, Bausch C, et al. Temperament and character personality profiles and personality disorders in chronic pain patients. Pain. 2007;133:197-209. (Pubitemid 350138322)
33. Malmgren-Olsson E, Bergdahl J. Temperament and character personality dimensions in patients with nonspecific musculoskeletal disorders. Clin J Pain. 2006;22(7):625-31. (Pubitemid 44310163)
34. Cloninger CR. Temperament and personality. Curr Opin Neurobiol. 1994;4(2):266-73. (Pubitemid 24126293)
35. Bailer UF, Frank GK, Price JC et al. Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa. Psychiatry Res. 2012.
36. • Wu IT, Lee IH, Yeh TL, et al. The association between the harm avoidance subscale of the Tridimensional Personality Questionnaire and serotonin transporter availability in the brainstem of male volunteers. Psychiatry Res. 2010;181(3):241-4. This is an interesting study on the relationship between harm avoidance and serotonergic neurotransmission.
37. Szekely A, Ronai Z, Nemoda Z, et al. Human personality dimensions of persistence and harm avoidance associated with DRD4 and 5-HTTLPR polymorphisms. Am J Med Genet B Neuropsychiatr Genet. 2004;126B(1):106-10. (Pubitemid 38420131)
38. Park JW, Han SR, Yang DW, et al. Serotonin transporter protein polymorphism and harm avoidance personality in migraine without aura. Headache. 2006;46(6):991-6. (Pubitemid 43794751)
39. Park JW, Kim JS, Lee HK, et al. Serotonin transporter polymorphism and harm avoidance personality in chronic tension-type headache. Headache. 2004;44(10):1005-9. (Pubitemid 39532342)
40. Jokela M, Lehtimaki T, Keltikangas-Jarvinen L. The serotonin receptor 2A gene moderates the influence of parental socioeconomic status on adulthood harm avoidance. Behav Genet. 2007;37(4):567-74. (Pubitemid 46956692)
41. Nakamura Y, Ito Y, Aleksic B, et al. Influence of HTR2A polymorphisms and parental rearing on personality traits in healthy Japanese subjects. J Hum Genet. 2010;55(12):838-41.
42. Melke J, Westberg L, Nilsson S, et al. A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch Gen Psychiatry. 2003;60(10):1017-23. (Pubitemid 37222085)
43. Hensler JG. Serotonergic modulation of the limbic system. Neurosci Biobehav Rev. 2006;30(2):203-14. (Pubitemid 41821809)
44. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986;4(3):167-226. (Pubitemid 17216108)
45. •• Ziv M, Tomer R, Defrin R, Hendler T. Individual sensitivity to pain expectancy is related to differential activation of the hippocampus and amygdala. Hum Brain Mapp. 2010;31:326-38. A seminal study confirming increased amygdala activation associated with anticipated threat of pain and high harm avoidance.
46. •• Knaster P, Estlander AM, Karlsson H, et al. Temperament traits and chronic pain: the association of harm avoidance and pain-related anxiety. PLoS One. 2012;7(10):e45672. This study proves the relationship between harm avoidance and pain-related fear.
47. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85(3):317-32. (Pubitemid 30214160)
48. • Jensen JN, Karpatschof B, Labriola M, Albertsen K. Do fear-avoidance beliefs play a role on the association between low back pain and sickness absence? A prospective cohort study among female health care workers. J Occup Environ Med. 2010;52(1):85-90. This prospective study shows the possibility of predicting number of sick days by fear-avoidance beliefs.
49. Nieto R, Miro J, Huguet A. The fear-avoidance model in whiplash injuries. Eur J Pain. 2009;13(5):518-23.
50. Turk DC, Wilson HD. Fear of pain as a prognostic factor in chronic pain: conceptual models, assessment, and treatment implications. Curr Pain Headache Rep. 2010;14(2):88-95.
51. Weisberg JN, Vaillancourt PD. Personality factors and disorders in chronic pain. Semin Clin Neuropsychiatry. 1999;4(3):155-66.
52. Grant BF, Hasin DS, Stinson FS et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2004.
53. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-III). 3rd ed. Washington, D.C.; 1980.
54. Fishbain DA, Goldberg M, Meagher BR, et al. Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain. 1986;26(2):181-97. (Pubitemid 16046063)
55. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical interview for DSM-III-R. Washington, D.C.: American Psychiatric Press, Inc.; 1990.
56. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinican interview for DSM-III-R Axis II disorders (SCID-II). Washington, D.C.: American Psychiatric Press, Inc.; 1990.
57. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). 3rd revised ed. Washington, D.C.; 1987.
58. Polatin PB, Kinney RK, Gatchel RJ, et al. Psychiatric illness and chronic low-back pain. The mind and the spine - which goes first? Spine (Phila Pa 1976). 1993;18(1):66-71. (Pubitemid 23060498)
59. Gatchel RJ, Garofalo JP, Ellis E, Holt C. Major psychological disorders in acute and chronic TMD: an initial examination. J Am Dent Assoc. 1996;127(9):1365-70. 72, 74.
60. Links PS, Eynan R. The relationship between personality disorders and axis i psychopathology: deconstructing comorbidity. Annu Rev Clin Psychol. 2012.
61. Rowe S, Jordan J, McIntosh V, et al. Dimensional measures of personality as a predictor of outcome at 5-year follow-up in women with bulimia nervosa. Psychiatry Res. 2011;185(3):414-20.
62. Kronstrom K, Salminen JK, Hietala J, et al. Personality traits and recovery from major depressive disorder. Nord J Psychiatry. 2011;65(1):52-7.
63. Simeon D, Hollander E. Treatment of Personality Disorders. The American Psychiatric Publishing Textbook of Psychopharmacology. Washington: American Psychiatric Publishing; 2009. p. 1267-86.
64. • Kampman O, Poutanen O, Illi A, et al. Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients. Eur Psychiatry. 2012;27(4):245-9. This study demonstrates the negative influence of harm avoidance on response to SSRI treatment in MD.
65. Kaneda A, Yasui-Furukori N, Nakagami T, et al. The influence of personality factors on paroxetine response time in patients with major depression. J Affect Disord. 2011;135(1-3):321-5.
66. Hirano S, Sato T, Narita T, et al. Evaluating the state dependency of the temperament and character inventory dimensions in patients with major depression: a methodological contribution. J Affect Disord. 2002;69(1-3):31-8. (Pubitemid 34722868)
67. Hruby R, Nosalova G, Ondrejka I, Preiss M. Personality changes during antidepressant treatment. Psychiatr Danub. 2009;21(1):25-32.
68. Hellerstein DJ, Kocsis JH, Chapman D, et al. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality. Am J Psychiatry. 2000;157(9):1436-44.
69. •• Quilty LC, Godfrey KM, Kennedy SH, Bagby RM. Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression. Psychother Psychosom. 2010;79(2):116-22. This study elegantly demonstrates that change in harm avoidance mediated the response to antidepressant treatment.
70. Tome MB, Cloninger CR, Watson JP, Isaac MT. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. J Affect Disord. 1997;44(2-3):101-9. (Pubitemid 27297848)
71. Bulik CM, Sullivan PF, Joyce PR, et al. Predictors of 1-year treatment outcome in bulimia nervosa. Compr Psychiatry. 1998;39(4):206-14. (Pubitemid 28326193)
72. Anderson CB, Joyce PR, Carter FA, et al. The effect of cognitive-behavioral therapy for bulimia nervosa on temperament and character as measured by the temperament and character inventory. Compr Psychiatry. 2002;43(3):182-8. (Pubitemid 34507465)
73. Joyce PR, Mulder RT, Luty SE, et al. Borderline personality disorder in major depression: symptomatology, temperament, character, differential drug response, and 6-month outcome. Compr Psychiatry. 2003;44(1):35-43. (Pubitemid 36056772)
74. Staud R. Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert Rev Neurother. 2012;12(5):577-85.
75. Salomons TV, Johnstone T, Backonja MM, et al. Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex. J Cogn Neurosci. 2007;19(6):993-1003. (Pubitemid 46849734)